Jeremy Clarkson's Prostate Cancer: What He Shared

What he said, and when

In June 2026, Jeremy Clarkson disclosed a prostate cancer diagnosis in the final two episodes of the fifth season of Clarkson's Farm, which were filmed in 2025.

"I disappeared the other week, and I had a biopsy, and it is cancer, and it's aggressive," he told his colleagues on the program. He also said the cancer had been caught at an early stage. Of the operation, he said: "The prostate, 10 percent of it's dead. The 10 percent where the cancer is." The Guardian described that as an operation to remove 10% of his prostate.

Days after the episodes aired, Clarkson told The Times he was in remission. He said a prostate-specific antigen test two months earlier had shown no indication of cancer. "It was an aggressive type of cancer," he said. "It could have spread, it could have gone into the pancreas, it could have gone anywhere, and that would have been trouble."

He has used the diagnosis to push one message. "I'm not just not dead, I'm perfectly fine," he said. "And the reason why I am fine is because the doctors caught the prostate cancer early, and they caught it early because I got tested."

This page reports only what he has said publicly. It does not infer his stage, his grade, or his prognosis.

"Aggressive" and "early" are not opposites

Those two words sound contradictory. They describe different things.

Aggressive refers to grade — how abnormal the cells look under a microscope. Pathologists score prostate cancer by pattern and combine the scores into a Grade Group from 1 to 5. Our page on what grade group means explains that scale.

Early refers to stage — how far the cancer has travelled.

A cancer can be high-grade and still confined to the gland. That combination is exactly why finding it matters: the biology is unfavorable, and the window is still open.

How prostate cancer is usually found

NCI notes that in the United States most prostate cancers are diagnosed through screening, so symptoms are uncommon at the point of diagnosis.

When local symptoms do appear, they come from the tumor pressing on the urethra: a weaker stream, hesitancy, urgency, waking at night to urinate, and a feeling of not emptying. NCI is explicit that these are nonspecific and point more toward benign prostatic hyperplasia — a non-cancerous enlargement — than toward cancer.

Diagnosis needs tissue. NCI says needle biopsy is the most common method, usually done through the rectum with ultrasound guidance.

PSA is a decision, not a verdict

PSA is a protein made by the prostate. A blood test measures it.

A raised PSA does not mean cancer. Infection and an enlarged prostate can both raise it, and a normal PSA does not rule cancer out.

The reason PSA screening is a discussion rather than a routine is overdiagnosis. Many prostate cancers grow so slowly that they would never have caused harm, and finding them can lead to treatment with real side effects for no benefit.

That trade-off is why NCI presents both benefits and harms rather than a blanket recommendation, and why the conversation should factor in age, family history, ancestry, and general health. Our page on prostate cancer screening sets out both sides, and our explainer on the PSA test covers what the number means.

When to get checked

Two thresholds are worth holding onto.

The first is a conversation, not a symptom. Men should discuss PSA testing with a clinician from around age 50, or earlier — often from 40 to 45 — with a father or brother who had prostate cancer, with a known BRCA1 or BRCA2 change in the family, or with Black ancestry, which carries higher risk.

The second is symptoms that need prompt review regardless: blood in the urine or semen, urinary changes that are new and persistent, and back, hip, or pelvic pain that does not settle. NCI lists that last group with anemia symptoms — breathlessness, deep fatigue, fast heartbeat, dizziness, pale skin — as signs of advanced disease.

New back pain with leg weakness, numbness, or loss of bladder or bowel control needs same-day care. That can mean pressure on the spinal cord.

What treatment can involve

Options depend on grade, stage, age, and preference.

For low-risk disease, active surveillance is standard: regular PSA tests, exams, imaging, and repeat biopsies, with treatment held back unless things change. NCI lists it among the options for stage I and stage II disease.

For disease that needs treating, the main routes are surgery to remove the prostate, external-beam radiation, and implanted radioactive seeds. Hormone therapy is added in higher-risk situations. Each carries costs, mainly to urinary control and sexual function.

What the numbers describe

About 333,830 new prostate cancer diagnoses and 36,320 deaths are projected in the United States for 2026 by the American Cancer Society, and SEER, NCI's cancer surveillance program, carries the figures. From NCI's own records, the median age at diagnosis is 68, and 43% of cases are found in men aged 65 to 74.

Sixty-nine percent is localized at diagnosis and 14% regional. Five-year relative survival for both is essentially 100%. Nine percent is distant, where it is 40.1%.

Across all stages it is 98.2% for men diagnosed from 2016 through 2022.

These are group figures, and stage drives all of them. They do not describe one person's course. The gap between the localized and distant rows is the argument for finding it early.

What this story cannot tell you

Clarkson's outcome does not predict anyone else's. Grade, stage, age, and general health all differ.

Remission is also not a finish line. Clarkson himself said he will keep having regular blood tests and knows the cancer could return. He put his odds at 60% no recurrence — that is his own framing of his situation, not a general statistic, and the real figure for any individual depends on details no public account contains.

His account also cannot settle whether you should have a PSA test. One man's early detection is a powerful story, not evidence about a population.

And a public figure's decision to have surgery says nothing about what suits anyone else. Surveillance, radiation, and hormone therapy are real options in different situations.

Sources

• AP: British TV personality Jeremy Clarkson reveals he has prostate cancer
• The Guardian: Jeremy Clarkson says he's in remission from prostate cancer
• Variety: Jeremy Clarkson says he's in remission from cancer
• The Hollywood Reporter: Jeremy Clarkson reveals prostate cancer diagnosis
• NCI PDQ: Prostate Cancer Treatment (Health Professional Version)
• NCI PDQ: Prostate Cancer Treatment (Patient Version)
• NCI SEER Stat Facts: Prostate Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.